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T-bet is a key modulator of IL-23-driven pathogenic
CD4þ T cell responses in the intestine
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IL-23 is a key driver of pathogenic Th17 cell responses. It has been suggested that the
transcription factor T-bet is required to facilitate IL-23-driven pathogenic effector functions;
however, the precise role of T-bet in intestinal T cell responses remains elusive. Here, we
show that T-bet expression by T cells is not required for the induction of colitis or the
differentiation of pathogenic Th17 cells but modiﬁes qualitative features of the IL-23-driven
colitogenic response by negatively regulating IL-23R expression. Consequently, absence of
T-bet leads to unrestrained Th17 cell differentiation and activation characterized by high
amounts of IL-17A and IL-22. The combined increase in IL-17A/IL-22 results in enhanced
epithelial cell activation and inhibition of either IL-17A or IL-22 leads to disease amelioration.
Our study identiﬁes T-bet as a key modulator of IL-23-driven colitogenic responses in the
intestine and has important implications for understanding of heterogeneity among
inﬂammatory bowel disease patients.
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T
h17 cells are enriched at mucosal sites, produce high
amounts of IL-17A, IL-17F and IL-22, and have an
essential role in mediating host protective immunity
against a variety of extracellular pathogens1. However, on the
dark side, Th17 cells have also been implicated in a variety of
autoimmune and chronic inﬂammatory conditions, including
inﬂammatory bowel disease (IBD)2. Despite intense interest, the
cellular and molecular cues that drive Th17 cells into a
pathogenic state in distinct tissue settings remain poorly deﬁned.
The Th17 cell programme is driven by the transcription factor
retinoid-related orphan receptor gamma-t (RORgt) (ref. 3),
which is also required for the induction and maintenance of
the receptor for IL-23 (refs 4,5). The pro-inﬂammatory cytokine
IL-23, composed of IL-23p19 and IL-12p40 (ref. 6), has been
shown to be a key driver of pathology in various murine models
of autoimmune and chronic inﬂammatory disease such as
experimental autoimmune encephalomyelitis (EAE)7, collagen
induced arthritis8 and intestinal inﬂammation9–12. Several lines
of evidence, predominantly derived from EAE, suggest that IL-23
promotes the transition of Th17 cells to pathogenic effector
cells9–12. Elegant fate mapping experiments of IL-17A-producing
cells during EAE have shown that the majority of
IL-17Aþ IFN-gþ and IL-17A IFN-gþ effector cells arise from
Th17 cell progeny13. This transition of Th17 cells into
IFN-g-producing ‘ex’ Th17 cells required IL-23 and correlated
with increased expression of T-bet. The T-box transcription
factor T-bet drives the Th1 cell differentiation programme14
and directly transactivates the Ifng gene by binding to its
promoter as well as multiple enhancer elements15. Indeed,
epigenetic analyses have revealed that the loci for T-bet and
IFN-g are associated with permissive histone modiﬁcations in
Th17 cells suggesting that Th17 cells are poised to express T-bet
which could subsequently drive IFN-g production16,17.
A similar picture is emerging in the intestine where IL-23
drives T-cell-mediated intestinal pathology which is thought to be
dependent on expression of T-bet18 and RORgt (ref. 19) by T
cells. In support of this we have recently shown that IL-23
signalling in T cells drives the emergence of IFN-g producing
Th17 cells in the intestine during chronic inﬂammation20.
Collectively these studies suggest a model whereby RORgt
drives differentiation of Th17 cells expressing high amounts of
IL-23R, and subsequently, induction of T-bet downstream of
IL-23 signalling generates IL-17Aþ IFN-gþ T cells that are
highly pathogenic. Indeed, acquisition of IFN-g production by
Th17 cells has been linked to their pathogenicity in several
models of chronic disease13,21–24 and a population of T cells
capable of producing both IL-17A and IFN-g has also been
described in intestinal biopsies of IBD patients25,26.
However, in the context of intestinal inﬂammation, it remains
poorly deﬁned whether the requirement for RORgt and T-bet
reﬂects a contribution of Th17 and Th1 cells to disease
progression or whether Th17 cells require T-bet co-expression
to exert their pathogenic effector functions. Here, we use two
distinct models of chronic intestinal inﬂammation and make the
unexpected ﬁnding that T-bet is dispensable for IL-23-driven
colitis. Rather the presence of T-bet serves to modify the
colitogenic response restraining IL-17 and IL-22 driven pathol-
ogy. These data identify T-bet as a key modulator of IL–23-driven
colitogenic effector responses in the intestine and have important
implications for understanding of heterogeneous immune
pathogenic mechanisms in IBD patients.
Results
IL-23 promotes IL-17Aþ IFN-cþ intestinal T cells. Using the T
cell transfer model of colitis, which involves the transfer of naı¨ve
CD4þ T cells into lymphopenic Rag1 / hosts27,28, we
previously demonstrated that direct signalling of IL-23 into
T cells promotes colitis and the emergence of IL-17Aþ IFN-gþ
T cells20. To assess the contribution of IL-23 signalling to the
development of intestinal inﬂammation and differentiation of
IL-17Aþ IFN-gþ T cells in a lymphocyte replete setting, we
induced colitis by oral infection with Helicobacter hepaticus (Hh)
and concomitant administration of IL-10R blocking antibody
(Hhþ anti-IL-10R)9. This T-cell-dependent model of colitis is
characterized by a mixed Th1/Th17 response and inﬂammation is
blocked in Il12p40 / mice (deﬁcient in both IL-12 and IL-23)
but not Il12p35 / mice (deﬁcient only in IL-12), inferring an
essential role for IL-23 in disease pathogenesis. Consistent with
this, we observed marked accumulation of IL-23R-expressing
Th17 cells29 in the colon during the course of infection
(Supplementary Fig. 1A,B). To assess the functional role of
IL-23R signalling, we induced colitis in wild type (WT) or
IL-23R-deﬁcient (Il23r / ) mice by infection with
Hhþ anti-IL-10R. As expected WT mice developed severe
colitis and typhlocolitis characterized by cellular inﬁltration,
broadening of crypts and epithelial hyperplasia (Fig. 1a–c). By
contrast, Il23r / mice showed only mild signs of inﬂammation
in the colon and caecum. Genetic ablation of IL-23R did not
affect the differentiation of IL-17Aþ IFN-g T cells but led to a
sixfold reduction in the frequency of IL-17Aþ IFN-gþ T cells
and a small decrease in IL-17A IFN-gþ T cells (Fig. 1d,e).
Together, these data demonstrate that IL-23 is essential for the
development of Hh-induced colitis and the emergence of
IL-17Aþ IFN-gþ T cells.
IL-23 signals are dispensable for T-bet and RORct expression.
Evidence obtained from in vitro studies suggests that IL-23 drives
the acquisition of IFN-g production by Th17 cells in a
T-bet-dependent manner21,30,31. In addition, IL-23 has been
shown to enhance RORgt expression in naive CD4þ T cells
transduced with IL-23R-expressing retrovirus4. Thus, IL-23 could
drive the differentiation of IL-17Aþ IFN-gþ T cells by virtue of
its ability to induce and/or maintain expression of RORgt and
T-bet. To address this, we generated mixed bone-marrow
chimaeras by reconstituting irradiated Rag1 / mice with WT
(CD45.1þ ) and Il23r / (CD45.2þ ) bone marrow cells at 1:1
ratio. Following reconstitution of the haematopoietic system, we
induced intestinal inﬂammation by infection with
Hhþ anti-IL-10R. This approach allowed us to investigate the
phenotype of WT and Il23r / CD4þ T cells exposed to the
same inﬂammatory environment. Indeed, intestinal pathology in
mixed bone-marrow chimaeras was indistinguishable from that
in WT mice (Supplementary Fig. 2A and Fig. 1a). Both WT and
Il23r / CD4þ T cells were able to accumulate in the colon
(Supplementary Fig. 2B) and we observed equivalent frequencies
and total numbers of IL-17Aþ IFN-g and IL-17A IFN-gþ
cells among WT and Il23r / T cells (Supplementary
Fig. 2C,D). By contrast, differentiation of IL-17Aþ IFN-gþ cells
was signiﬁcantly reduced in Il23r / CD4þ T cells indicating
that IL-23 signalling directly into T cells in a cell autonomous way
is required for the emergence of this effector cell type20.
Next, we assessed the expression of RORgt and T-bet protein
by cytokine producing T cells of WT and Il23r / origin. As
expected, IL-17Aþ IFN-g cells expressed high amounts of
RORgt and IL-17A IFN-gþ cells expressed high amounts of
T-bet, whereas co-expression of both RORgt and T-bet was
exclusive to IL-17Aþ IFN-gþ T cells (Supplementary Fig. 2E–G).
Noticeably, there were no discernible differences in RORgt or
T-bet protein amounts between IL-17A or IFN-g single producers
of WT and Il23r / origin (Supplementary Fig. 2G). In
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addition, the remaining IL-17Aþ IFN-gþ cells detectable in T
cells derived from Il23r / bone marrow expressed equivalent
amounts of T-bet and RORgt compared with their WT counter-
parts (Supplementary Fig. 2G). These results demonstrate that
cell-intrinsic IL-23 signals are required for the emergence of
IL-17Aþ IFN-gþ T cells but are dispensable for the maintenance
of RORgt and T-bet expression in intestinal CD4þ T cells under
inﬂammatory conditions.
RORct but not T-bet is required for T cell transfer colitis. To
elucidate the impact of RORgt and T-bet expression on the
colitogenic potential of T cells, we transferred Rag1 / mice
with CD4þ T cells from C57BL/6 WT, Tbx21 / or Rorc /
donors and assessed the development of colitis. T cell transfer
colitis is a useful model to dissect the contribution of adaptive
immune cells to the development of the disease as genes can be
selectively ablated in the T cell donors hence avoiding
confounding effects on other immune populations. In keeping
with previous reports19 Rorc / T cells, which are deﬁcient in
both RORg and RORgt, induced only mild colitis upon transfer
into Rag1 / recipients (Fig. 2a,b). Consistent with the
attenuated histological features, we detected reduced amounts
of pro-inﬂammatory cytokines IL-17A, IL-22 and IFN-g in colon
explant cultures of Rorc / T cell recipients (Fig. 2c). Strikingly,
transfer of Tbx21 / CD4þ T cells led to the development of a
similar degree of intestinal inﬂammation as transfer of WT T cells
(Fig. 2a,b). Despite equivalent pathology, analysis of cytokine
secretion in colon explant cultures revealed a distinct
inﬂammatory signature in recipients of Tbx21 / T cells,
characterized by signiﬁcantly elevated amounts of the Th17
signature cytokines IL-17A and IL-22 (Fig. 2c). Surprisingly,
transfer of Tbx21 / T cells only marginally affected IFN-g
amounts, suggesting that T-bet-independent IFN-g secretion by T
cells, or IFN-g expressing innate cells, contribute to IFN-g
production in this setting.
Further analysis showed that dysregulated Th2 or Foxp3þ
regulatory T cell (Treg cells) responses are unlikely to account
for the difference in colitogenic potential of T-bet and
RORgt-deﬁcient T cells. We did not detect any signiﬁcant
differences in the frequency of Foxp3þ Treg cells, IL-4 or IL-13
expressing cells between Rorc / and Tbx21 / T cells
(Supplementary Fig. 3A–C).
T-bet is dispensable for IL-17Aþ IFN-cþ intestinal T cells.
Next we addressed the impact of T-bet or RORgt-deﬁciency on
intestinal CD4þ T cell differentiation. Consistent with their role
in T helper cell development, deﬁciency in T-bet led to impaired
differentiation of IFN-gþ cells while the emergence of IL-17Aþ
cells was markedly reduced in RORgt-deﬁcient T cells (Fig. 3a).
The attenuated intestinal pathology observed in recipients of
Rorc / T cells (Fig. 2a) correlated with a signiﬁcantly decreased
frequency and total number of IL-17Aþ IFN-gþ T cells in the
colon (Fig. 3b,c). By contrast, T-bet deﬁciency did not affect the
differentiation and accumulation of IL-17Aþ IFN-gþ T cells
(Fig. 3a–c), indicating that T-bet is dispensable for the generation
of this effector cell population. Together, these data reinforce the
requirement for RORgt in the generation of intestinal Th17 cells
and provide evidence that T-bet is dispensable for the differ-
entiation of intestinal IL-17Aþ IFN-gþ T cells.
T-bet deﬁciency promotes an exacerbated Th17-type response.
Our transfer of Tbx21 / T cells revealed a striking increase in
the frequency of IL-17Aþ IFN-g cells (Fig. 3) and we reasoned
that T-bet-deﬁciency could impact on Th17 cell cytokine
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Figure 1 | IL-23 signalling is required for bacteria-driven T-cell-dependent colitis and the emergence of IL-17Aþ IFN-cþ T cells. C57BL/6 WT and
Il23r/ mice were infected orally with Hh and received weekly i.p. injections of IL-10R blocking antibody. Mice were killed at 4 weeks post infection and
assessed for intestinal inﬂammation. (a) Colitis scores. (b) Typhlitis sores. (c) Representative photomicrographs of colon and caecum ( 10 magniﬁcation;
scale bars, 200mM). (d) Representative ﬂow cytometry plots of colonic lamina propria gated on viable CD4þ T cells. (e) Frequencies of IL-17Aþ and/or
IFN-gþ CD4þ Tcells present in the colon. Data represent pooled results from two independent experiments (n¼ 12 for WT, n¼ 10 for Il23r/ ). Bars are
the mean and each symbol represents an individual mouse. *Po0.05, ***Po0.001 as calculated by Mann–Whitney U test.
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production. Therefore, we transferred WT or Tbx21 / CD4þ
T cells into Rag1 / recipients and measured the expression of
RORgt, IL-17A, IL-17F and IL-22 by CD4þ T cells isolated from
the colon. In agreement with our earlier ﬁndings, Tbx21 /
T cells gave rise to signiﬁcantly increased frequencies of RORgt-
expressing T cells capable of producing IL-17A (Fig. 4a).
Furthermore, T-bet deﬁciency also led to a dramatic expansion of
IL-17F and IL-22-expressing cells, which constituted only a minor
fraction in WT T cells (Fig. 4a,b). By contrast, the frequency of
granulocyte-macrophage colony-stimulating factor (GM-CSF)
and IFN-g producing cells was signiﬁcantly reduced in T-bet-
deﬁcient T cells as compared with WT T cells. When analysed in
more detail we noted that the production of IL-17A, IL-17F and
IL-22 increased speciﬁcally in T-bet-deﬁcient IL-17Aþ IFN-gþ T
cells as compared with WT T cells whereas IFN-g production
decreased overall in the absence of T-bet as expected
(Supplementary Fig. 4A). Similarly, GM-CSF production was also
generally reduced in Tbx21 / CD4þ T cells further suggesting
a shift in the qualitative nature of the T cell response.
Next, we compared the expression of genes that are down-
stream of IL-17A, IL-17F and IL-22 signalling in colon
homogenates of Rag1 / recipients of WT or Tbx21 /
T cells. Transcript expression of Csf3, Cxcl1, Cxcl2, Reg3g,
S100a8 and S100a9 were signiﬁcantly increased in the colon of
Rag1 / recipients of Tbx21 / T cells (Fig. 4c). Consistent
with this, we also found increased numbers of neutrophils in the
colonic lamina propria of these mice (Fig. 4d). To test possible
interactions between IL-22 and IL-17A on expression of these
genes we isolated epithelial cells from the colon of Rag1 / mice
and stimulated them with IL-17A, IL-22 or combination of both
cytokines. We found a marked synergistic increase in the
expression of the neutrophil chemoattractants S100a8 and
S100a9 (ref. 32) messenger RNA (mRNA) following stimulation
with IL-17A and IL-22 (Fig. 4e and Supplementary Fig. 4B).
Together, our data demonstrate that colitis induced by Tbx21 /
T cells is characterized by an exacerbated Th17-type response and
that synergistic activity of IL-22 and IL-17A on epithelial cells
may result in enhanced neutrophil recruitment and development
of intestinal inﬂammation with distinct hall marks.
T-bet-deﬁcient CD4þ T cells are hyper-responsive to IL-23.
Next, we sought to compare gene-expression signatures and
functional properties of pathogenic T cells generated from WT
and Tbx21 / T cells. To investigate this, we puriﬁed CD4þ
T cells from the inﬂamed colon of Rag1 / mice that had been
transferred with an equal number of WT (CD45.1þ ) and
Tbx21 / (CD45.2þ ) T cells. Intestinal pathology of mice
receiving WT and Tbx21 / T cells was indistinguishable from
that in mice transferred with WT or Tbx21 / only T cells
(Fig. 5a). Importantly, the increased differentiation of Tbx21 /
T cell progeny into IL-17Aþ IFN-gþ T cells was preserved in the
co-transfer (Fig. 5b and Supplementary Fig. 5A) further
supporting the notion that T-bet is dispensable for acquisition of
IFN-g production by Th17 cells. Comparison of gene-expression
signatures showed that T-bet-deﬁcient T cells had signiﬁcantly
higher expression of Rorc, Il23r, Ccr6 and Il1r1 indicating a
speciﬁc cell-intrinsic role for T-bet in the repression of Th17
signature genes (Fig. 5c and Supplementary Fig. 5B). In addition,
Tbx21 / T cells had upregulated expression of neutrophil
chemoattractant Cxcl3 and decreased expression of the gene
encoding GM-CSF (Csf2). Interestingly, we found similar
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Figure 2 | RORct but not T-bet expression by CD4þ T cells is required for the development of T cell transfer colitis. C57BL/6 Rag1 / mice were
injected i.p. with 4 105 CD4þCD25CD45RBhi T cells from C57BL/6 WT, Rorc / or Tbx21 / donors. Mice were killed when recipients of
Tbx21 / T cells developed clinical signs of disease (4–6 weeks) and assessed for intestinal inﬂammation. (a) Colitis scores. (b) Representative
photomicrographs of proximal colon sections ( 10 magniﬁcation; scale bars, 200mM). (c) Concentration of cytokines released from colon explants into
the medium after overnight culture. Data represent pooled results from two independent experiments (n¼ 14 for WT, n¼ 11 for Rorc / , n¼ 14 for
Tbx21 / ). Bars are the mean and each symbol represents an individual mouse. Bars are the mean and error bars represent s.e.m. *Po0.05, **Po0.01,
***Po0.001 as calculated by Kruskal–Wallis one-way ANOVA with Dunn’s post-test.
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amounts of mRNA for Il10 and Tgfb3 (Supplementary Fig. 5B)
suggesting that these cytokines do not contribute to the observed
differences in pathogenic effector function between WT and
Tbx21 / T cells.
We were intrigued by the fact that Il23r and Csf2 appeared to
be differentially expressed in WT versus Tbx21 / T cells and
tested whether T-bet would be directly involved in regulating
their transcription. We performed ChIP experiments in CD4þ T
cells cultured in vitro under Th0 or Th1 conditions and analysed
the recruitment of T-bet to the transcription start site (TSS) of
Csf2 and to a speciﬁc region in intron 3 of Il23r where T-bet
binding has been detected according to two independent T-bet
ChIP-Seq experiments33,34. To correlate T-bet binding with gene
activity we analysed in parallel the recruitment of RNA
polymerase II (RNA Pol II) as well as the occurrence of the
open-chromatin-associated histone mark H3K4me3 at the TSS of
Csf2 and Il23r. T-bet was robustly recruited to Csf2 and Il23r in
Th1 cells and despite elevated amounts of H3Kme3 at both genes
only Csf2 showed enhanced transcriptional activity, as measured
by the recruitment of RNA Pol II (Supplementary Fig. 5C). To
further investigate the role of T-bet in the transcriptional
regulation of Csf2 and Il23r we performed ChIP experiments
on progeny of WT and Tbx21 / CD4þ T cells sort-puriﬁed
from T cell co-transfer experiments described above. In the
absence of T-bet, the open-chromatin mark H3K4me3 was
increased at the Il23r TSS as compared with WT cells and
transcription of the Il23r genes was upregulated substantially in
Tbx21 / progeny (Fig. 5d). This was in contrast to the Csf2
gene where T-bet deﬁciency resulted in decreased occupancy of
both H3K4me3 and RNA Poll II (Fig. 5d). These data provide a
molecular basis for our functional studies and reveal opposing
functions of T-bet leading to positive regulation of Csf2 but
negative regulation of Il23r expression.
Given the increased amounts of Il23r expression, we reasoned that
the exacerbated Th17 response induced by transfer of Tbx21 /
T cells could be the result of enhanced responsiveness to IL-23.
Stimulation of colonic WT T cells with IL-23 resulted in
phosphorylation of STAT3 and this was greatly enhanced in colonic
Tbx21 / T cells (Fig. 5e), suggesting that T-bet-deﬁcient T cells are
hyper-responsive to IL-23 due to higher expression of IL-23R.
Analysis of cytokine production by sort-puriﬁed colonic T cells
showed increased secretion of IL-17A and IL-22 in unstimulated and
IL-23-activated Tbx21 / compared with WT T cells (Fig. 5f).
IL-23-stimulated IFN-g production was also increased in Tbx21 /
T cells relative to unstimulated controls whereas IL-23 had no effect
on GM-CSF production in WT or T-bet deﬁcient T cells (Fig. 5f).
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To investigate the potential mechanism responsible for
T-bet-independent IFN-g production, we measured induction
of Eomesodermin (Eomes) and Runt-related transcription factor
3 (Runx3) downstream of IL-23 stimulation in sort-puriﬁed
WT and Tbx21 / colonic effector T cells. Eomes is a paralogue
to T-bet with a known role in regulating IFN-g production in
both CD4þ and CD8þ T cells35–37. Eomes was detected in
unstimulated Tbx21 / T cells and its expression was further
induced in response to IL-23 stimulation. In contrast, Eomes
protein amounts were at the limit of detection in unstimulated
and IL-23-stimulated WT T cells (Fig. 5e). In line with these
results, we found that intracellular expression of Eomes was
highly upregulated in colonic T-bet-deﬁcient effector T cells as
compared with their WT counterparts (Supplementary Fig. 6A).
However, o10% of IL-17Aþ IFN-gþ Tbx21 / T cells
expressed Eomes compared with B75% of IL-17A IFN-gþ
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Figure 4 | T-bet-deﬁcient CD4þ T cells promote an exacerbated Th17-type inﬂammatory response. C57BL/6 Rag1 / mice were injected i.p. with
4x105 CD4þCD25CD45RBhi T cells from C57BL/6 WT or Tbx21 / donors. Mice were killed when recipients of Tbx21 /T cells developed clinical
signs of disease (4–6 weeks). (a) Representative plots of cytokines and transcription factors in WTor Tbx21 / colonic CD4þ T cells. (b) Frequency of
IL-17Aþ , IL-17Fþ, IL-22þ , GM-CSFþ or IFN-gþ colonic T cells in WT or Tbx21 / . (c) quantitative reverse transcription PCR (qRT-PCR) analysis of
mRNA levels of indicated genes in colon tissue homogenates. (d) Total number of neutrophils (CD11bþ Gr1high) in the colon. (e) Primary epithelial cells
were isolated from the colon of steady state C57BL/6 Rag1 / mice and stimulated with 10 ngml 1 cytokines for 4 h after which cells were harvested and
analysed by qRT-PCR for the indicated genes. Data in b–d represent pooled results from two independent experiments (n¼ 14 for WT, n¼ 11 for Tbx21 / ).
Bars are the mean and error bars represent s.e.m. Data in e are pooled results from four independent experiments, bars are the mean and error bars
represent s.e.m. *Po0.05, **Po0.01, ***Po0.001 as calculated by Mann–Whitney U test.
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T cells (Supplementary Fig. 6B) suggesting that this factor might
drive IFN-g expression speciﬁcally in the latter population. Runx3
has been shown to promote IFN-g secretion directly either
through binding to the Ifng promoter38 or indirectly through
induction of Eomes39. Runx3 was induced in WT and T-bet-
deﬁcient T cells with greater fold induction observed in
Tbx21 / T cells (Fig. 5e). Thus, Eomes and Runx3 appear to
be induced downstream of IL-23R signalling in Tbx21 /
CD4þ T cells and could potentially contribute to
T-bet-independent IFN-g production.
T-bet-deﬁcient colitis depends on IL-23, IL-17A and IL-22. To
investigate whether IL-23 has a functional role in the induction of
colitis by T-bet-deﬁcient T cells, Rag1 / and Il23a /
Rag / mice were transferred with WT or Tbx21 / T cells.
As expected, transfer of WT or Tbx21 / T cells induced severe
intestinal inﬂammation in Rag1 / hosts. By contrast, colitis
was signiﬁcantly decreased when WT or Tbx21 / T cells were
transferred into IL-23 deﬁcient Il23a /Rag1 / recipients
(Fig. 6a,b). To test which effector cytokines were required for
colitis induced by T-bet-deﬁcient T cells, we transferred cohorts
of Rag1 / recipients with WT or Tbx21 / T cells and
administered neutralizing antibodies to IL-17A or IL-22.
Although neutralization of IL-17A or IL-22 did not signiﬁcantly
reduce inﬂammation in recipients of WT T cells, blockade of
either cytokine abrogated intestinal pathology in Rag1 / mice
transferred with Tbx21 / CD4þ T cells (Fig. 6a,b). To conﬁrm
that IL-17A/IL-22 produced by CD4þ T cells are indeed
pathogenic factors in Tbx21 / driven T cell transfer colitis, we
stimulated intestinal epithelial cells with supernatant of
IL-23-activated WT and Tbx21 / T cells. Compared with WT
supernatant, the supernatant of Tbx21 / T cells induced a
potent epithelial cell response (Fig. 6c). Similar to the in vivo
blockade experiments, neutralization of IL-17A or IL-22 was only
effective in Tbx21 / T cells suggesting that augmented cyto-
kine production may be a major driver in colitis induced by
T-bet-deﬁcient T cells. Taken together these results show that
IL-23 promotes a distinct Th17-dependent pathogenic T cell
response in the absence of T-bet.
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Discussion
In the present study we show that bacteria-driven colitis is
associated with the IL-23-dependent emergence of
IFN-g-producing Th17 cells co-expressing RORgt and T-bet.
Strikingly, while RORgt is required for the differentiation of
IFN-g-producing Th17 cells and induction of colitis, T-bet is
dispensable for the emergence of IL-17Aþ IFN-gþ T cells and
intestinal pathology. Our results show that instead of a
mandatory role in the colitogenic response, the presence of
T-bet modulates the qualitative nature of the IL-23-driven
intestinal inﬂammatory response. In the presence of T-bet,
IL-23-driven colitis is multifunctional in nature and not
functionally dependent on either IL-17A or IL-22. By contrast,
in the absence of T-bet a highly polarized colitogenic Th17 cell
response ensues which is functionally dependent on both IL-17A
and IL-22. T-bet-deﬁcient T cells are hyper-responsive to IL-23
resulting in enhanced STAT3 activation and downstream
cytokine secretion providing a mechanistic basis for the
functional changes. These data newly identify T-bet as a key
modulator of IL-23-driven colitogenic CD4þ T cell responses.
Contrary to our expectations T-bet expression by CD4 T cells
was not required for their pathogenicity. In keeping with the
negative effect of T-bet on Th17 differentiation40–42, we observed
highly polarized Th17 responses in T-bet-deﬁcient intestinal T
cells. Early studies demonstrated that IFN-g could suppress the
differentiation of Th17 cells40 and thus the reduced IFN-g
production by Tbx21 /T cells could facilitate Th17 cell
generation. However, our co-transfer studies revealed
unrestrained Th17 differentiation of Tbx21 / T cells even in
the presence of WT T cells, suggesting a cell autonomous role for
T-bet-mediated suppression of the Th17 programme. Indeed, the
role of T-bet as a transcriptional repressor of the Th17 cell fate
has been described recently. For example, T-bet physically
interacts with and sequesters Runx1, thereby preventing Runx1-
mediated induction of RORgt and Th17 cell differentiation43. In
addition, T-bet binds directly to and negatively regulates
expression of many Th17-related genes15,34 and we identiﬁed
IL23r to be repressed in a T-bet-dependent manner. In line with
this we show here that T-bet-deﬁcient intestinal T cells express
higher amounts of Il23r as well as Rorc. This resulted in enhanced
IL-23-mediated STAT3 activation and increased production of
IL-17A and IL-22. It has also been suggested that T-bet activation
downstream of IL-23R signalling is required for pathogenic
IL-23-driven T cell responses43,44. However, we did not ﬁnd a
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***Po0.001 as calculated by Kruskal–Wallis one-way ANOVA with Dunn’s post-test.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11627
8 NATURE COMMUNICATIONS | 7:11627 | DOI: 10.1038/ncomms11627 | www.nature.com/naturecommunications
role for IL-23 in the induction and/or maintenance of T-bet
expression and colitis induced by T-bet-deﬁcient T cells was
IL-23 dependent. Collectively, these ﬁndings demonstrate that
T-bet deﬁciency leads to unrestrained expansion of colitogenic
Th17 cells, which is likely mediated through enhanced activation
of the IL-23R-STAT3 pathway.
The observation that T-bet-deﬁcient T cells retain their
colitogenic potential is in stark contrast to earlier studies. Neurath
et al.18 convincingly showed that adoptive transfer of Tbx21 /
CD4þ T cells into severe combined immunodeﬁciency (SCID)
recipients failed to induce colitis and this correlated with reduced
IFN-g and increased IL-4 production. Another study revealed that
IL-4 plays a functional role in inhibiting the colitogenic potential of
Tbx21 / T cells, as recipients of Stat6 /Tbx21 / T cells
developed severe colitis37. Importantly, the intestinal inﬂammation
that developed in recipients of Stat6 /Tbx21 / T cells could be
blocked by administration of IL-17A neutralizing antibody,
suggesting that the potent inhibitory effect of IL-4/STAT6 signals
on Th17 differentiation normally prevent colitis induced by
Tbx21 / T cells37. Various explanations could account for the
discrepancy between our study and those earlier ﬁndings. First, in
contrast to the published reports, we used naı¨ve Tbx21 / CD4þ
T cells from C57BL/6 mice instead of BALB/c mice. An important
difference between Tbx21 / CD4þ T cells from these genetic
backgrounds appears to be their differential susceptibility to
suppression by IL-4/STAT6 signals. We found that transfer of
Tbx21 / T cells induced IL-17A-dependent colitis despite
increased frequencies of IL-4-expressing cells in the intestine. This
discrepancy may be due to higher amounts of IL-4 produced by
activated CD4þ T cells from BALB/c versus C57BL/6 mice45,
leading to the well-described Th2-bias of the BALB/c strain45.
Second, differences in the composition of the intestinal microbiota
between animal facilities can have a substantial effect on skewing
CD4þ T cells responses. In particular, the Clostridium-related
segmented ﬁlamentous bacteria (SFB) have been shown to drive
the emergence of IL-17 and IL-22 producing CD4þ T cells in
the intestine46. Importantly, the ability of naı¨ve CD4þ T cells
to induce colitis is dependent on the presence of intestinal
bacteria, as germ-free mice do not develop pathology upon
T cell transfer47. In line with this, we previously described that
colonization of germ-free mice with intestinal microbiota
containing SFB was necessary to restore the development of
colitis47. Since our Rag1 / colony is SFBþ and the presence
of SFB was not reported in the previous studies, it is possible
that differences in SFB colonization status contributed to
the observed differences in pathogenicity of Tbx21 / T cells.
It is important to note that T-bet-deﬁcient T cells did not
induce more severe colitis than WT T cells but rather promoted a
distinct mucosal inﬂammatory response. Colitis induced by WT
T cells is characterized by a multifunctional response with high
amounts of IFN-g and GM-CSF and a lower IL-17A and IL-22
response. Consistent with this, we have shown that blockade of
GM-CSF abrogates T cell transfer colitis48 as well as bacteria-
driven intestinal inﬂammation49 in T-bet sufﬁciency whereas
blockade of IL-17A or IL-22 fails to do so. By contrast T-bet
deﬁciency leads to production of high amounts of IL-17A and
IL-22 in the colon and neutralization of either was sufﬁcient to
reduce intestinal pathology. Our in vitro experiments suggest that
IL-17A and IL-22 synergise to promote intestinal epithelial cell
responses, which may in part explain the efﬁcacy of blocking
IL-17A or IL-22 in colitis induced by T-bet-deﬁcient T cells. A
similar synergistic interplay has been described in the lung where
IL-22 served a tissue protective function in homeostasis but
induced airway inﬂammation in the presence of IL-17A (ref. 50).
This highlights the complexity of the system in health and
disease, and the need for a controlled production of both
cytokines. We describe here only one mechanism of how
IL-17A/IL-22 induce a context-speciﬁc epithelial cell response
that potentially impacts on the order or composition of immune
cell inﬁltration. Overall, these results provide a new perspective
on T-bet, revealing its role in shaping the qualitative nature of the
IL-23-driven colitogenic T cell response.
We also describe here the unexpected ﬁnding that a substantial
proportion of T-bet-deﬁcient intestinal T cells retain the ability to
express IFN-g. To investigate the potential mechanisms respon-
sible for T-bet-independent IFN-g production by intestinal
CD4þ T cells we focused on two transcription factors, Runx3
and Eomes. Runx3 has been shown to promote IFN-g expression
directly through binding to the Ifng promoter38 and Eomes is
known to compensate for IFN-g production in T-bet-deﬁcient
Th1 cells37. We found IL-23-mediated induction of Runx3
protein in WT and Tbx21 / T cells isolated from the intestine,
thus identifying Runx3 downstream of IL-23R signalling. By
contrast, we could only detect Eomes protein and its induction by
IL-23 in T-bet-deﬁcient but not WT T cells. Thus, Runx3 and
Eomes are activated in response to IL-23 in T-bet-deﬁcient cells
and are likely to be drivers of T-bet-independent IFN-g
production. In support of this we found that the majority of
T-bet-deﬁcient IL-17A IFN-gþ T cells expressed Eomes.
However, only a minor population of IL-17Aþ IFN-gþ T cells
stained positive for Eomes, suggesting the existence of alternative
pathways for IFN-g production by Th17 cells. Intriguingly, a
recent study identiﬁed Runx3 and Runx1 as the transcriptional
regulators critical for the differentiation of IFN-g-producing
Th17 cells51. The author’s demonstrated that ectopic expression
of Runx transcription factors was sufﬁcient to induce IFN-g
production by Th17 cells even in the absence of T-bet. These
ﬁndings, combined with our data on Runx3 activation
downstream of IL-23R signalling strongly suggest that Runx3
rather than Eomes is driving IFN-g expression by intestinal
Th17 cells.
We have not formally addressed the role of IFN-g in colitis
driven by T-bet-deﬁcient T cells. A recent report by Zimmer-
mann et al.52 found that antibody-mediated blockade of IFN-g
ameliorates colitis induced by WT or T-bet-deﬁcient T cells
suggesting IFN-g also contributes to the colitogneic response
mediated by T-bet-deﬁcient T cells as originally described for WT
T cells53,54. By contrast with our results the Zimmerman study
found that IL-17A blockade exacerbated colitis following transfer
of Tbx21 / T cells. The reason for the differential role of
IL-17A in the two studies is not clear but it is notable that the
Zimmerman study was performed in the presence of co-infection
with SFB and Hh, and this strong inﬂammatory drive may alter
the pathophysiological role of particular cytokines. Together the
data indicate that T-bet deﬁciency in T cells does not impede
their colitogenic activity but that the downstream effector
cytokines of the response are context dependent.
In conclusion, our data further underline the essential role for
IL-23 in intestinal inﬂammation and demonstrate that T-bet is an
important modulator of the IL–23-driven effector T cell response.
The colitogenic T cell response in a T-bet sufﬁcient environment
is multifunctional with a dominant GM-CSF and IFN-g response.
By contrast T-bet-deﬁcient colitogenic responses are dominated
by IL-17A and IL-22-mediated immune pathology. These results
may have signiﬁcant bearing on human IBD where it is now
recognized that differential responsiveness to treatment may
reﬂect considerable disease heterogeneity. As such, identiﬁcation
of suitable biomarkers such as immunological parameters, that
allow stratiﬁcation of patient groups, is becoming increasingly
important55. Genome-wide association studies have identiﬁed
polymorphisms in loci related to innate and adaptive immune
arms that confer increased susceptibility to IBD. Among these are
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Th1 (STAT4, IFNG and STAT1) as well as Th17-related genes
(RORC, IL23R and STAT3) (refs 56,57). Thus, detailed proﬁling
of the T cell response in IBD patients may help identify
appropriate patient groups that are most likely to beneﬁt from
therapeutic blockade of certain effector cytokines. Finally, our
studies highlight the importance of IL-23 in the intestinal
inﬂammatory hierarchy and suggest that IL-23 could be an
effective therapeutic target across a variety of patient groups.
Methods
Mice. Wild type C57BL/6, C57BL/6 Tbx21 / (obtained from Jackson Labora-
tories) congenic B6.SJL-Cd45, C57BL/6 Rag1 / , C57BL/6 Rorc / (obtained
from Dan Littman) C57BL/6 Il23r / , C57BL/6.IL-23Rgfp/þ (obtained from
Mohamed Oukka) and C57BL/6 Il23a /Rag1 / (obtained from Dan Cua)
mice were bred and maintained under speciﬁc pathogen-free conditions in
accredited animal facilities at the University of Oxford. All procedures were
conducted in accordance with the UK Scientiﬁc Procedures Act of 1986. All
experimental protocols were approved by the UK Home Ofﬁce and the Ethical
Review Committee of the Oxford University Medical Sciences Division. Both
female and male mice were used in experiments and animals were assigned
randomly to experimental groups. Each cage contained animals of all the different
experimental groups whenever possible.
Mice were negative for Helicobacter spp. and other known intestinal pathogens
and were more than 6 weeks old when ﬁrst used for T cell transfer or when used as
recipients/donors in mixed bone-marrow chimera experiments.
T cell transfer colitis. For naı¨ve T cell transfer colitis, 4 105 CD4þCD25
CD45RBhi T cells were injected i.p. into Rag1 / or Il23a /Rag1 / reci-
pients. In co-transfer experiments, 2  105 CD4þCD25CD45RBhi T cells from
each source were mixed and injected i.p. into Rag1 / hosts. Where indicated,
mice were injected with anti-IL-17A (1mg per mouse every 3 days, clone 17F3
BioXCell), anti-IL-22 (0.125mg per mouse every 3 days, Genentech, clone 8E11) or
isotype control for the duration of the experiment. Mice were killed at indicated
time points or killed when weight loss approached 20% of the original body weight
at the start of the experiment.
Induction of Hh/anti-IL-10R colitis. Mice were fed 1 108 cfu Hh by oral gavage
with a 22G curved needle on days 0 and 1 of the experiment. In some experiments,
mice also received 1mg of an anti-IL-10R blocking antibody by i.p. injection once
weekly starting at the day of Hh infection.
Generation of mixed bone-marrow chimeras. Bone marrow isolated from
Il23r / mice was mixed at a 1:1 ratio with bone marrow taken from B6.SJL-Cd45
mice and injected intravenously into gamma-irradiated (5.5Gy, 550Rad) C57BL/6
Rag1 / recipients and chimaeras were used in experiments 48 weeks after
injection.
Histological assessment of intestinal inﬂammation. Proximal, mid- and distal-
colon samples were ﬁxed in buffered 10% formalin solution. Parafﬁn-embedded
sections were cut (5mm) and stained with haematoxylin and eosin, and inﬂam-
mation was scored in a blinded fashion using a previously described scoring
system58. Brieﬂy, each sample was graded semiquantitatively from 0 to 3 for the
four following criteria: degree of epithelial hyperplasia and goblet cell depletion;
leucocyte inﬁltration in the lamina propria; area of tissue affected; and the presence
of markers of severe inﬂammation such as crypt abscesses, submucosal
inﬂammation and ulcers. Scores for each criterion were added to give an overall
inﬂammation score for each sample of 0–12. The total colonic score was calculated
as the average of the individual scores from the sections of proximal-, mid- and
distal-colon.
Isolation of leucocyte subpopulations and ﬂow cytometry. Cell suspensions
from spleen, mesenteric lymph nodes (MLN) and the lamina propria were pre-
pared as described previously59 and ﬁrst incubated with anti-CD16/CD32
(eBioscience) to prevent nonspeciﬁc binding. Single cell suspensions were stained
with antibodies against CD4, CD11b, CD25, GR1, TCR-b, CD45.1, CD45.2, IL-4,
IL-13, IL-17A, IL-22, IFN-g, EOMES, RORgt, Foxp3, (all from eBioscience),
CD45RB, IL-17F and T-bet (all from Biolegend). Intracellular staining was
performed as follows: cells were restimulated for 4 h with 0.1 mgml 1 phorbol 12-
myristate 13-acetate (PMA) and 1 mgml 1 ionomycin (both Sigma Aldrich) plus
Brefeldin A (eBioscience), washed and incubated with anti-CD16/CD32. Cells were
washed and stained for surface markers indicated above and ﬁxed in eBioscience
Fix/Perm buffer, followed by permeabilization in eBioscience permeabilization
buffer for 1 h in the presence of antibodies. Cells were acquired with a BD LSR2
and analysis was performed with FlowJo (Tree Star) software
Colon explant cultures. Small pieces of colon (B5mm of mid-colon) were
isolated, rinsed in PBS/BSA and weighed. Colon explants were cultured overnight
in Roswell Park Memorial Institute medium (RPMI; Invitrogen) containing 10%
FCS, 2mM L-glutamine, 0.05mM 2-mercaptoethanol and 100Uml 1 each of
penicillin and streptomycin (complete media) in 24-well tissue culture plates.
Cytokine amounts in the supernatants were determined by Bender assay according
to the manufacturers’ protocol (eBioscience) and concentrations normalized to the
weight of the explants.
T cell cultures. CD4þTCR-bþCD45.1þ (WT progeny) and CD4þTCR-bþ
CD45.1 (Tbx21 / progeny) T cells were sort-puriﬁed from the colon of
C57BL/6 Rag1 / recipient mice. Cells were either lysed for quantitative PCR
(qPCR) or plated at 2 105 cells per well in ﬂat bottomed 96-well plates in RPMI
(Invitrogen) containing 10% FCS, 2mM l-glutamine, 0.05mM 2-mercaptoethanol
and 100Uml 1 each of penicillin and streptomycin (complete media). IL-23 was
added at 20 ngml 1 (R&D) for 12 h after which cells were harvested and lysed for
immunoblot analysed. Supernatants were collected and cytokine secretion quan-
tiﬁed by Bender assay (eBioscience) as per the manufacturers’ protocol.
Epithelial cell cultures. Primary epithelial cells were isolated from steady state
colon of C57BL/6 Rag1 / mice. Brieﬂy, colons were cut open longitudinally,
washed in cold PBS to remove colon content and cut into 1 cm pieces. Epithelial
cells were liberated by a 10-min wash with RPMI containing 10% FCS and 5mM
EDTA in a shaking incubator. Supernatant was ﬁltered, cells pelleted at 1,500 r.p.m.
and plated at 2 105 cells per well in ﬂat bottom 96-well plates in complete media.
Recombinant IL-17 and IL-22 (Biolegend) were added for 4 h at the concentration
indicated after which cells were harvested and lysed for qPCR.
In some experiments, CD4þTCR-bþCD45.1þ (WT progeny) and
CD4þTCR-bþCD45.1 (Tbx21 / progeny) T cells were sort-puriﬁed from
the colon of C57BL/6 Rag1 / recipient mice. Cells were stimulated with IL-23
(10 ngml 1) for 12 h, the supernatant collected and added at 20% of total culture
volume to epithelial cells in combination with blocking antibodies as indicated:
anti-IL-17A (10 mgml 1, clone 17F3 BioXCell), anti-IL-22 (10 mgml 1,
Genentech) or isotype control. Cells were stimulated for 4 h after which cells
were harvested and lysed for qPCR.
qPCR. RNA was extracted according to the manufacturers’ protocol (RNeasy,
Qiagen) and cDNA synthesis was performed using Superscript III reverse tran-
scription and Oligo dT primers (both from Invitrogen). qPCR reactions were
performed using TaqMan Gene Expression Assays and normalized to hypox-
anthine-guanine phosphoribosyltransferase (HPRT; all from Applied Biosystems).
Samples were assayed in duplicate on a Bio-Rad CFX96 RT-qPCR or ABI Vii
machine and differences were calculated using the 2DC(t) method.
Total protein extracts and immunoblot analysis. Total protein extracts were
prepared by lysing cells in protein lysis buffer (20mM Tris pH 8.0, 300mM NaCl,
10% Glycerol, 1% NP-40) for 30min on ice. After centrifugation at full speed to
pellet debris, equal amounts of protein were resolved by SDS–polyacrylamide gel
electrophoresis and analysed with anti-pY705-STAT3 (clone D3A7, Cat. Nr. 9145,
1/1,000 dilution, Cell Signaling), anti-STAT3 (clone 79D7, Cat. Nr. 4904, 1/1,000
dilution, Cell Signaling), anti-EOMES (clone 21Mags8, Cat. Nr. 14-4876-80, 1/500
dilution, eBiosciences), anti-Actin (clone AC-15, Cat. Nr. A5541, 1/1,0000 Sigma)
or anti-Runx3 (1/1,000, gift from Yoram Groner). Images in Fig. 5e have been
cropped for presentation. Full size images are presented in Supplementary Fig. 7A–E.
Chromatin immunoprecipitation. For in vitro ChIP assays, naı¨ve CD4þ
CD25CD44CD62Lþ T cells were sort-puriﬁed from spleens and lymphnodes
of steady state C57BL/6 mice. Cells were plated at 3x105 cells per well in complete
media in 48-well plates coated with anti-CD3 (5 mgml 1). Antibodies and cyto-
kines were added at the following concentrations: anti-CD28 (2 mgml 1) and IL-2
(100Uml 1, Peprotech) for Th0 or anti-CD28 (2 mgml 1), IL-2 (100Uml 1),
IL-12 (10 ngml 1, Peprotech) and anti-IL-4 (10 mgml 1, Biolegend) for Th1.
Cells were cultured for 36 h and stimulated with fresh IL-12 (10 ngml 1) for the
last 4 h. For ex vivo ChIP assays, CD4þTCR-bþCD45.1þ (WT progeny) and
CD4þTCR-bþCD45.1 (Tbx21 / progeny) T cells were sort-puriﬁed from the
colon of C57BL/6 Rag1 / recipient mice.
ChIP assays were performed as described60. Brieﬂy, cells were washed once with
PBS and ﬁxed with 1% paraformaldehyde (Sigma) for 10min at room temperature.
125mM of Tris pH 7 was added to stop the reaction. Cells were pelleted, washed,
lysed in sonication buffer (10mM Tris-HCl pH 8.0, 100mM NaCl, 1mM EDTA,
0.5mM EGTA, 0.1% Na-Deoxycholate, 0.5% Na-Lauroylsarcosine; all from Sigma)
and sonicated using a Bioruptor Pico (Diagenode) to obtain a fragment size of
around 500 base pairs. Lysates were centrifuged at full speed for 5min at 4 C and
an aliquot (10%) was taken at this point as input control DNA. Remaining lysates
were incubated with antibodies pre-bound to Protein G magnetic beads (Live
Technologies) at 4 C on a rotator overnight. The following antibodies were used,
T-bet (Cat. Nr. sc-21003, 3 ug per IP, Santa Cruz), RNA Pol II (sc-899, 2 ug per IP,
Santa Cruz) or H3K4me3 (Pab-003-050, 3 ug per IP, Diagenode). Beads were then
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placed on a magnet, washed ﬁve times with wash buffer (50mM Hepes-KOH pH
7.6, 500mM LiCl, 1mM EDTA, 1% NP-40, 0.7% Na-deoxycholate; all from Sigma)
and once with Tris-EDTA (TE) containing 50mM NaCl. After the ﬁnal wash,
beads were resuspended in elution buffer (1 TE containing 2% SDS) and reverse
cross-linking performed at 65 C in a shaking heat block overnight. Reverse cross-
linking was similarly performed on input control DNA. The immunoprecipitated
DNA fragments and input control DNA were puriﬁed using QIAquick PCR
Puriﬁcation Kit (Qiagen) as per the manufacturers’ protocol and then analysed by
quantitative reverse transcription PCR on a ABI Vii machine with SYBR Premix Ex
Taq II master mix (Takara Bio) and the following primers: locus encoding Csf2
TSS, 50-agagaaaggctaaggtcctgagga-30 and 50-ccaggaggttcagggcttcttt-3’, locus
encoding Il23r TSS, 50-agggctctgctgacatttccat-30 and 50-acagctgcctctatgtatctcagga-30 ,
or locus encoding part of Il23r intron 3, 50-gtcactgagcacctgtcccttc-30 and 50-
aaacccctcaaccaacagcagg-30 .
Statistical analysis. Where appropriate the Mann–Whitney U test or Student’s
t-test was used. For comparison of more than two groups a Kruskal–Wallis one-
way ANOVA followed by a Dunn’s post hoc test or one-way ANOVA followed by a
Bonferroni multiple comparison test was performed. All statistical analysis was
calculated in Prism (Graphpad). Differences were considered to be statistically
signiﬁcant when Pr0.05.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors on request.
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